At EURETINA, experts ask if OCT-A is a must-have in the retina care workflow

News
Video

During the European Society of Retina Specialists (EURETINA) meeting in Paris, France, Andreas Pollreisz, MD, presented on new imaging technologies and multimodal imaging techniques.

In this video, learn more about the research and about Pollreisz, who is an assistant professor of ophthalmology at Medical University of Vienna in Austria. He was an invited speaker during the EURETINA session on diabetic retinopathy and diabetic macular oedema (DMO), focusing on optical coherence tomography angiography (OCT-A). His presentation was titled "OCT-A widefield imaging: must have or nice to have?"

Watch the full video to hear how Prof Pollreisz answered that question.

And, don't miss these other highlights:

  • Clinical tips for imaging the retinal periphery in patients with diabetes
  • Which imaging modalities will still be used in 10 years
  • The current limitations of OCT-A, and the ways in which it is underutilised
  • How artificial intelligence could alter the clinical approach to ischemia, DMO, neovascularisation and other retinal pathologies

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.